DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
China flag China · Delayed Price · Currency is CNY
19.90
+0.32 (1.63%)
Jan 22, 2026, 3:00 PM CST

SHA:603233 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
1,138914.751,1661,036791.231,062
Upgrade
Depreciation & Amortization
1,5841,5841,4481,2881,149170.77
Upgrade
Other Amortization
311.36311.36248.28243.75218.08169.03
Upgrade
Loss (Gain) From Sale of Assets
-19.21-19.21-3.43-18.73-5.632.53
Upgrade
Asset Writedown & Restructuring Costs
38.638.66.21---
Upgrade
Loss (Gain) From Sale of Investments
-11.57-11.57-10.9412.89-44-20.91
Upgrade
Provision & Write-off of Bad Debts
15.2815.2815.9223.611.495.6
Upgrade
Other Operating Activities
1,344347.74388.19294.24247.4955.02
Upgrade
Change in Accounts Receivable
-1,588-1,588-364.73-953.44-317.98-75.05
Upgrade
Change in Inventory
126.08126.08-104.16-157.39-745.93-539.61
Upgrade
Change in Accounts Payable
1,3951,395389.071,967235.181,113
Upgrade
Change in Other Net Operating Assets
3.283.2819.0448.5465.6314.45
Upgrade
Operating Cash Flow
4,3263,1063,1743,7571,5551,954
Upgrade
Operating Cash Flow Growth
35.10%-2.13%-15.51%141.58%-20.42%14.41%
Upgrade
Capital Expenditures
-403.71-1,476-1,797-1,035-1,295-792.32
Upgrade
Sale of Property, Plant & Equipment
8.2828.5314.6437.3721.6112.35
Upgrade
Cash Acquisitions
-72.75-520.82-502.3-305.25-529.82-289.75
Upgrade
Divestitures
1.591.59----
Upgrade
Investment in Securities
-1.4811.34-2.165.54814.11-19.16
Upgrade
Other Investing Activities
13.8515.86-11.83.1721.3517.64
Upgrade
Investing Cash Flow
-454.22-1,939-2,303-1,294-967.7-1,071
Upgrade
Short-Term Debt Issued
-191.8816--1,570
Upgrade
Long-Term Debt Issued
-3,1371,0941,095145.63-
Upgrade
Total Debt Issued
2,1643,3291,1101,095145.631,570
Upgrade
Short-Term Debt Repaid
---4.9---118.8
Upgrade
Long-Term Debt Repaid
--3,422-2,388-1,655-1,321-
Upgrade
Total Debt Repaid
-4,374-3,422-2,392-1,655-1,321-118.8
Upgrade
Net Debt Issued (Repaid)
-2,210-92.44-1,282-560.15-1,1751,451
Upgrade
Issuance of Common Stock
----13.25100.01
Upgrade
Repurchase of Common Stock
-101.8-101.8-0.95-0.11-0.44-
Upgrade
Common Dividends Paid
-751.39-753.21-604.51-420.29-534.28-333.27
Upgrade
Other Financing Activities
-10415.52238.1546.9884.37-8.41
Upgrade
Financing Cash Flow
-3,167-931.93-1,649-933.57-1,6121,209
Upgrade
Foreign Exchange Rate Adjustments
0.320.32----
Upgrade
Net Cash Flow
704.64235.37-778.781,529-1,0252,092
Upgrade
Free Cash Flow
3,9221,6301,3772,722260.051,162
Upgrade
Free Cash Flow Growth
163.63%18.39%-49.40%946.64%-77.61%-3.71%
Upgrade
Free Cash Flow Margin
14.62%6.15%5.61%12.81%1.55%7.96%
Upgrade
Free Cash Flow Per Share
3.491.441.222.390.231.02
Upgrade
Cash Income Tax Paid
1,2171,2681,108939.01897.77846.9
Upgrade
Levered Free Cash Flow
3,8312,0782,2612,191412.54740.11
Upgrade
Unlevered Free Cash Flow
3,9702,2342,4112,336545.07747.29
Upgrade
Change in Working Capital
-74.19-74.19-84.49876.98-812.84509.69
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.